Recent data indicates that retatrutide, a dual-action medication, might represent a major step in body reduction . This treatment combines the properties of a GLP-1 receptor and a GIP analog, seemingly offering a greater impact than existing approaches . Clinical trials have shown positive outcomes, including substantial declines in weight and adva